Lee, Chan-Ho <br/><br/>
Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury.  [electronic resource] 

 -  The journal of sexual medicine  May 2011 
 - 1330-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1743-6109 
<br/><br/><label>Standard No.: </label>10.1111/j.1743-6109.2011.02228.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Erectile Dysfunction--drug therapy<br/>Hedgehog Proteins--analysis<br/>Hypoxia-Inducible Factor 1, alpha Subunit--analysis<br/>Male<br/>Nerve Growth Factor--analysis<br/>Nitric Oxide Synthase Type I--analysis<br/>Nitric Oxide Synthase Type III--analysis<br/>Penile Erection--drug effects<br/>Penis--chemistry<br/>Phosphodiesterase 5 Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Endothelin B--analysis<br/>Sulfonamides--administration & dosage<br/>Transforming Growth Factor beta1--analysis